Too much for Medicare?, hot, hot housing and America’s ammo shortage
CNBC
Biogen’s new Alzheimer’s Disease drug is being hailed as a medical breakthrough.
But could its $56,000 per year price tag be too much for Medicare to handle? We’ll debate.
Plus, home prices just posted their biggest gain in the history of the Case-Shiller Index, up 15% in April.
Can the hot housing market keep rolling? And are investors actually driving up prices? We’ll ask Coldwell Banker’s CEO.
And, record gun sales are leading to an ammunition shortage across America. Can the manufacturers catch up to demand? We’ll explore.